SE0100193D0 - Method for the preparation of citalopram - Google Patents

Method for the preparation of citalopram

Info

Publication number
SE0100193D0
SE0100193D0 SE0100193A SE0100193A SE0100193D0 SE 0100193 D0 SE0100193 D0 SE 0100193D0 SE 0100193 A SE0100193 A SE 0100193A SE 0100193 A SE0100193 A SE 0100193A SE 0100193 D0 SE0100193 D0 SE 0100193D0
Authority
SE
Sweden
Prior art keywords
citalopram
preparation
palladium catalyst
zinc
cyanide
Prior art date
Application number
SE0100193A
Other languages
English (en)
Other versions
SE0100193L (sv
SE516690C2 (sv
Inventor
Hans Petersen
Michael Harold Rock
Henrik Svane
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SE0100193D0 publication Critical patent/SE0100193D0/sv
Publication of SE0100193L publication Critical patent/SE0100193L/sv
Publication of SE516690C2 publication Critical patent/SE516690C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
SE0100193A 1999-06-25 2001-01-24 Förfarande för framställning av citalopram SE516690C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (3)

Publication Number Publication Date
SE0100193D0 true SE0100193D0 (sv) 2001-01-24
SE0100193L SE0100193L (sv) 2001-04-25
SE516690C2 SE516690C2 (sv) 2002-02-12

Family

ID=8099035

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100193A SE516690C2 (sv) 1999-06-25 2001-01-24 Förfarande för framställning av citalopram

Country Status (36)

Country Link
US (2) US20020077353A1 (sv)
EP (1) EP1159274B1 (sv)
JP (1) JP3447267B2 (sv)
KR (1) KR100491368B1 (sv)
CN (2) CN1502616A (sv)
AR (1) AR020863A1 (sv)
AT (3) ATE235478T1 (sv)
AU (2) AU1374500A (sv)
BG (1) BG65574B1 (sv)
BR (1) BR9917368B1 (sv)
CA (2) CA2290127C (sv)
CH (1) CH691305A5 (sv)
CZ (1) CZ292198B6 (sv)
DE (2) DE69906389T2 (sv)
DK (2) DK1159274T3 (sv)
EA (1) EA002560B1 (sv)
ES (2) ES2194545T3 (sv)
FI (1) FI108641B (sv)
GB (2) GB2357761B (sv)
HK (1) HK1049002B (sv)
HU (1) HUP0103235A3 (sv)
IL (2) IL145959A0 (sv)
IS (1) IS2343B (sv)
IT (1) ITMI991581A1 (sv)
MX (1) MXPA01010989A (sv)
NO (1) NO328542B1 (sv)
NZ (1) NZ514979A (sv)
PL (1) PL205579B1 (sv)
PT (1) PT1159274E (sv)
SE (1) SE516690C2 (sv)
SI (1) SI1159274T1 (sv)
SK (1) SK285813B6 (sv)
TR (1) TR200103702T2 (sv)
UA (1) UA63034C2 (sv)
WO (1) WO2000013648A2 (sv)
ZA (1) ZA200108854B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200101796T2 (tr) 1998-12-23 2001-11-21 H. Lundbeck A/S 5-Siyanofitalitin preparasyonuna yönelik metot
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
HUP0200169A3 (en) 1999-10-25 2002-11-28 Lundbeck & Co As H Method for the preparation of citalopram
GB2360281B (en) 1999-10-25 2002-01-16 Lundbeck & Co As H Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
WO2001047909A1 (en) 1999-12-28 2001-07-05 H. Lundbeck A/S Method for the preparation of citalopram
PL198803B1 (pl) 1999-12-30 2008-07-31 Lundbeck & Co As H Sposób wytwarzania 5-cyjano-3H-izobenzofuran-1-onu
ES2206177T3 (es) 2000-01-14 2004-05-16 H. Lundbeck A/S Metodo para la preparacion de 5-cianoftalida.
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
BR0109176A (pt) 2000-03-13 2003-04-22 Lundbeck & Co As H Método para preparação de citalopram e composto da fórmula
IL151488A0 (en) 2000-03-14 2003-04-10 Lundbeck & Co As H Method for the preparation of citalopram
EP1274699A1 (en) * 2000-03-16 2003-01-15 H. Lundbeck A/S Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
EA200200332A1 (ru) * 2000-07-06 2002-06-27 Х.Лундбекк А/С Способ получения циталопрама
CA2354880C (en) * 2000-08-18 2003-06-03 H. Lundbeck A/S Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
PT1181272E (pt) * 2000-12-28 2003-01-31 Lundbeck & Co As H Processo para a preparacao de citalopram puro
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
RU2003130073A (ru) * 2001-03-09 2005-04-10 Ранбакси Лабораторис Лимитед (In) Способ получения циталопрама
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
PE20040991A1 (es) 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (sv) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
JP3526581B2 (ja) * 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CZ292911B6 (cs) * 1997-11-11 2004-01-14 H. Lundbeck A/S Způsob výroby citalopramu
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
TR200101796T2 (tr) * 1998-12-23 2001-11-21 H. Lundbeck A/S 5-Siyanofitalitin preparasyonuna yönelik metot
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) * 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
GB2360281B (en) * 1999-10-25 2002-01-16 Lundbeck & Co As H Method for the preparation of citalopram
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
CA2354880C (en) * 2000-08-18 2003-06-03 H. Lundbeck A/S Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
PT1181272E (pt) * 2000-12-28 2003-01-31 Lundbeck & Co As H Processo para a preparacao de citalopram puro

Also Published As

Publication number Publication date
KR100491368B1 (ko) 2005-05-24
AT409961B (de) 2002-12-27
HK1049002B (zh) 2004-12-31
ES2194545T3 (es) 2003-11-16
SE0100193L (sv) 2001-04-25
CZ292198B6 (cs) 2003-08-13
GB0101504D0 (en) 2001-03-07
FI20010155A (sv) 2001-02-09
EP1159274B1 (en) 2003-03-26
IS2343B (is) 2008-02-15
AR020863A1 (es) 2002-05-29
ITMI991581A1 (it) 2001-01-15
CA2290127C (en) 2005-01-25
CA2290127A1 (en) 2000-12-25
ITMI991581A0 (it) 1999-07-15
TR200103702T2 (tr) 2002-06-21
WO2000013648A8 (en) 2000-05-11
ATA904199A (de) 2002-05-15
CZ2001320A3 (en) 2001-05-16
WO2000013648B1 (en) 2001-03-15
PL346237A1 (en) 2002-01-28
JP3447267B2 (ja) 2003-09-16
EP1159274A2 (en) 2001-12-05
CH691305A5 (de) 2001-06-29
ES2189699A1 (es) 2003-07-01
AU2001100440B4 (en) 2002-01-24
SE516690C2 (sv) 2002-02-12
ZA200108854B (en) 2002-08-28
GB2357761A (en) 2001-07-04
HK1049002A1 (en) 2003-04-25
UA63034C2 (en) 2004-01-15
PT1159274E (pt) 2003-08-29
CN1367786A (zh) 2002-09-04
IL145959A (en) 2007-07-24
BG106191A (en) 2002-08-30
GB2357761B (en) 2001-09-05
US20090088469A1 (en) 2009-04-02
GB2354239A (en) 2001-03-21
BR9917368B1 (pt) 2010-02-09
DE69906389D1 (de) 2003-04-30
PL205579B1 (pl) 2010-05-31
HUP0103235A2 (hu) 2002-01-28
NO20010319L (no) 2001-02-23
NO328542B1 (no) 2010-03-15
AU1374500A (en) 2000-03-27
SK18402001A3 (sk) 2002-06-04
AT4365U1 (de) 2001-06-25
IS5861A (is) 2001-02-23
DK200100060A (da) 2001-04-10
DE69906389T2 (de) 2003-10-30
CA2475401A1 (en) 2000-12-25
EA200101072A1 (ru) 2002-02-28
MXPA01010989A (es) 2002-06-04
AU2001100440A4 (en) 2001-11-01
NO20010319D0 (no) 2001-01-19
BG65574B1 (bg) 2009-01-30
WO2000013648A3 (en) 2000-07-13
CN1502616A (zh) 2004-06-09
JP2002526386A (ja) 2002-08-20
SK285813B6 (sk) 2007-08-02
FI108641B (sv) 2002-02-28
NZ514979A (en) 2004-01-30
ATE235478T1 (de) 2003-04-15
US20020077353A1 (en) 2002-06-20
GB0105182D0 (en) 2001-04-18
SI1159274T1 (en) 2003-10-31
GB2354239B (en) 2001-06-06
EA002560B1 (ru) 2002-06-27
WO2000013648A2 (en) 2000-03-16
DE19983487C1 (de) 2002-07-25
BR9917368A (pt) 2002-03-05
DK1159274T3 (da) 2003-07-21
CN1140521C (zh) 2004-03-03
KR20020012204A (ko) 2002-02-15
HUP0103235A3 (en) 2003-01-28
IL145959A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
SE0100193D0 (sv) Method for the preparation of citalopram
SE0100194D0 (sv) Method for the preparation of citalopram
BR0213421A (pt) método para formar uma camada de metal condutor em uma superfìcie não condutora
FR16C0033I2 (fr) Methode de formation de composes d'hydroxypyrone de fer
DE50214456D1 (de) Modifizierte l-nukleinsäure
TR200103847T2 (tr) 3-Hidroksipropanal hazırlanması için usul
GR20010100097A (el) Μεθοδος παρασκευης της σιταλοπραμης
EP1129214A4 (en) STIMULATION OF THE CATALYSIS DEPOSIT OF REPORTING ENZYMES
NZ504084A (en) Processes for producing 7-isoindolinequinolonecarboxylic derivatives and its intermediates, as well as salts of 7-isoindolinequinolonecarboxylic acid derivatives, its hydrates and composition comprising the same as active ingredient
TR200003003T2 (tr) Titanyum bileşimi, içeren katalizatör oluşumu
ATE189334T1 (de) Elektromagnetisches relais und verfahren zu dessen herstellung
DE60325573D1 (de) Verwendung von metallgluconatsalzen bei der herstellung von antimikrobiell wirksamen substraten
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
DE602004004810D1 (de) Herstellungsverfahren für optisch reine 2-(4-hydroxyphenoxy)-propionsäureverbindungen
EA199800349A1 (ru) Способ получения гипофосфита никеля
ATE130292T1 (de) Hydrierung.
ES2189512T3 (es) Procedimiento para la obtencion estereoselectiva de ciclohexilcianhidrinas substituidas.
DE59701119D1 (de) Verfahren zur herstellung eines elektromagnetischen relais
DK0924195T3 (da) Fremgangsmåde til fremstilling af aminocyanacetamid
SE0101323D0 (sv) New process
DE502005008987D1 (de) Strahlungsarmer elektromagnetischer Hörer
ES2160491A1 (es) Secuencia aminoacida apta para afectar la actividad enzimatica de pectin metilesterasas (pme) y secuencia nucleotica para enzimas que afectan petin metilesterasas comprendiendo dicha secuencia aminoacida.
ES2115846T3 (es) Metodo mejorado para la preparacion de acidos piridin-2,3-dicarboxilicos.
EA200100064A1 (ru) Способ получения замещенных пиридинкарбоновых кислот
MXPA04000513A (es) Proceso para la preparacion de 4-metilamino-4-fenilpiperidina.

Legal Events

Date Code Title Description
NUG Patent has lapsed